How impaired is too impaired? Exploring futile neuropsychological test patterns as a function of dementia severity and cognitive screening scores.

cognitive screening dementia dementia severity neuropsychological evaluation neuropsychological testing older adult

Journal

Journal of neuropsychology
ISSN: 1748-6653
Titre abrégé: J Neuropsychol
Pays: England
ID NLM: 101468753

Informations de publication

Date de publication:
09 2021
Historique:
revised: 04 02 2021
received: 20 11 2020
accepted: 17 02 2021
pubmed: 4 3 2021
medline: 29 10 2021
entrez: 3 3 2021
Statut: ppublish

Résumé

Some older adults cannot meaningfully participate in the testing portion of a neuropsychological evaluation due to significant cognitive impairments. There are limited empirical data on this topic. Thus, the current study sought to provide an operational definition for a futile testing profile and examine cognitive severity status and cognitive screening scores as predictors of testing futility at both baseline and first follow-up evaluations. We analysed data from 9,263 older adults from the National Alzheimer's Coordinating Center Uniform Data Set. Futile testing profiles occurred rarely at baseline (7.40%). There was a strong relationship between cognitive severity status and the prevalence of futile testing profiles, χ

Identifiants

pubmed: 33655681
doi: 10.1111/jnp.12243
pmc: PMC8413392
mid: NIHMS1702552
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

410-427

Subventions

Organisme : NIA NIH HHS
ID : P50 AG005142
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG010133
Pays : United States
Organisme : NIA NIH HHS
ID : P50 AG047266
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG008017
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG010161
Pays : United States
Organisme : NIA NIH HHS
ID : P50 AG025688
Pays : United States
Organisme : NIA NIH HHS
ID : P50 AG005133
Pays : United States
Organisme : NIA NIH HHS
ID : P50 AG005138
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG072977
Pays : United States
Organisme : NIA NIH HHS
ID : P50 AG047366
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG019610
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG028383
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG013854
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG053760
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG066444
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG062428
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG010124
Pays : United States
Organisme : NIA NIH HHS
ID : P50 AG023501
Pays : United States
Organisme : NIA NIH HHS
ID : P50 AG005146
Pays : United States
Organisme : NIA NIH HHS
ID : U24 AG072122
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG062421
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG035982
Pays : United States
Organisme : NIA NIH HHS
ID : P50 AG008702
Pays : United States
Organisme : NIA NIH HHS
ID : U01 AG016976
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG008051
Pays : United States
Organisme : NIA NIH HHS
ID : P50 AG005681
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG013846
Pays : United States
Organisme : NIA NIH HHS
ID : P50 AG047270
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG062429
Pays : United States
Organisme : NIA NIH HHS
ID : P50 AG005136
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG049638
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG012300
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG062422
Pays : United States
Organisme : NIA NIH HHS
ID : P50 AG016573
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG062715
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG010129
Pays : United States

Informations de copyright

© 2021 The British Psychological Society.

Références

Arch Clin Neuropsychol. 2009 Feb;24(1):31-46
pubmed: 19395355
J Alzheimers Dis. 2016;51(3):889-903
pubmed: 26923025
Arch Clin Neuropsychol. 2017 Jun 1;32(4):491-498
pubmed: 28334244
Alzheimer Dis Assoc Disord. 2018 Oct-Dec;32(4):351-358
pubmed: 30376508
J Alzheimers Dis. 2017;58(3):789-801
pubmed: 28482634
Neuropsychologia. 2011 Jan;49(1):43-8
pubmed: 21029744
Int Psychogeriatr. 1997;9 Suppl 1:173-6; discussion 177-8
pubmed: 9447441
Clin Neuropsychol. 2020 Jan;34(1):56-87
pubmed: 31014166
J Int Neuropsychol Soc. 2007 May;13(3):490-500
pubmed: 17445298
Arch Clin Neuropsychol. 2016 May;31(3):206-30
pubmed: 26984127
J Psychiatr Res. 1975 Nov;12(3):189-98
pubmed: 1202204
J Int Neuropsychol Soc. 2013 Mar;19(3):272-83
pubmed: 23298442
J Int Neuropsychol Soc. 2004 Oct;10(6):807-17
pubmed: 15637771
Neuropsychology. 2020 Sep;34(6):629-640
pubmed: 32338945
J Am Geriatr Soc. 2015 Nov;63(11):2370-4
pubmed: 26503296
Arch Clin Neuropsychol. 2017 Aug 1;32(5):574-584
pubmed: 28419177
Arch Clin Neuropsychol. 2020 Jul 21;:
pubmed: 32710607
Clin Neuropsychol. 2017 Apr;31(3):487-500
pubmed: 27937143
J Int Neuropsychol Soc. 2020 Jul;26(6):576-586
pubmed: 32063246
J Int Neuropsychol Soc. 2008 May;14(3):463-78
pubmed: 18419845
Aging (Milano). 1996 Dec;8(6):379-85
pubmed: 9061124
Arch Clin Neuropsychol. 2020 Jul 24;35(5):562-575
pubmed: 32128586
Alzheimers Dement. 2013 Jan;9(1):63-75.e2
pubmed: 23305823
Clin Neuropsychol. 2014;28(1):65-83
pubmed: 24404822
Cochrane Database Syst Rev. 2016 Jan 13;(1):CD011145
pubmed: 26760674
Biling (Camb Engl). 2012 Jul;15(3):594-615
pubmed: 25364296
Arch Neurol. 1994 Jan;51(1):41-5
pubmed: 8274108
Arch Clin Neuropsychol. 2010 Feb;25(1):14-21
pubmed: 20015965
Eur J Neurol. 2002 Mar;9(2):125-36
pubmed: 11882053
Int Psychogeriatr. 2009 Dec;21(6):1096-104
pubmed: 19712540
Alzheimer Dis Assoc Disord. 2020 Jul-Sep;34(3):191-197
pubmed: 32483017
Clin Neuropsychol. 2020 Oct 26;:1-18
pubmed: 33103615
Neurobiol Aging. 1996 Jan-Feb;17(1):123-30
pubmed: 8786794
Neurology. 1997 Jun;48(6):1508-10
pubmed: 9191756
J Am Geriatr Soc. 2005 Apr;53(4):695-9
pubmed: 15817019
Alzheimer Dis Assoc Disord. 2018 Jan-Mar;32(1):10-17
pubmed: 29240561
Alzheimers Dement (Amst). 2018 Nov 03;10:773-781
pubmed: 30505927
Alzheimer Dis Assoc Disord. 2020 Oct-Dec;34(4):333-338
pubmed: 32701514
Clin Neuropsychol. 2020 Apr;34(3):437-453
pubmed: 32037942
Psychiatr Pol. 2016 Oct 31;50(5):1039-1052
pubmed: 27992895
J Int Neuropsychol Soc. 2019 Feb;25(2):204-214
pubmed: 30457078
Arch Clin Neuropsychol. 2019 Jan 24;35(1):75-89
pubmed: 31236576
Neurology. 1993 Nov;43(11):2412-4
pubmed: 8232972
Appl Neuropsychol Adult. 2021 Jul-Aug;28(4):449-463
pubmed: 31424275
Arch Clin Neuropsychol. 2003 Jul;18(5):551-5
pubmed: 14591449

Auteurs

Andrew M Kiselica (AM)

Department of Health Psychology, University of Missouri, Columbia, Missouri, USA.

Ellen Johnson (E)

Department of Health Psychology, University of Missouri, Columbia, Missouri, USA.
Department of Psychology, Ohio University, Athens, Ohio, USA.

Jared F Benge (JF)

Department of Neurology, University of Texas at Austin, Texas, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH